“When the late Paul Poth was diagnosed with a form of cancer so rare there was no treatment, he helped to launch a highly promising area of cancer research that is giving new hope to patients.”
A great piece from a Massachusetts General Hospital newsletter on TargetCancer Foundation’s work with MGH that recently led to a new cholangiocarcinoma clinical trial.
You can help support this clinical trial! Learn more.
We recently announced the exciting news that research initiated by TargetCancer Foundation has led to a new cholangiocarcinoma clinical trial. We are truly proud to have been a part of the process leading to this trial, and now we’re just as excited to provide funding to support the trial itself. Continue reading
As 2014 comes to a close, so does our fifth anniversary year. And what an amazing year it has been! A whirlwind to say the least, but we saw the most significant growth and progress in the history of TargetCancer Foundation.
And there’s no time to rest in year six- our next round of grants will be awarded in January, and we already have events on the calendar for the winter and spring of 2015. But in the meantime, here’s a look back at some of our accomplishments from the past year.
Menu